Statins and the risk of colorectal carcinoma: A nested case-control study in veterans with diabetes

American Journal of Gastroenterology

Volumn 104, Issue 5, 2009, Pages 1241-1248

  Hachem, Christine ^a,b,c   Morgan, Robert ^d   Johnson, Michael ^e   Kuebeler, Mark ^a   El Serag, Hashem ^a,b  

^a MICHAEL E DEBAKEY VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

^c SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF TEXAS SCHOOL OF PUBLIC HEALTH   (United States)

^e UNIVERSITY OF HOUSTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CLOFIBRATE; COLESEVELAM; COLESTIPOL; COLESTYRAMINE; EZETIMIBE; FENOFIBRATE; GEMFIBROZIL; GLITAZONE DERIVATIVE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN; NICOTINIC ACID; NONSTEROID ANTIINFLAMMATORY AGENT; SIMVASTATIN; SULFONYLUREA;

AGED; ARTICLE; CANCER PREVENTION; CANCER RISK; CASE CONTROL STUDY; CAUCASIAN; CHEMOPROPHYLAXIS; CHOLECYSTECTOMY; COLORECTAL CARCINOMA; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC PATIENT; DISEASE SEVERITY; DYSLIPIDEMIA; ENTERITIS; FEMALE; HUMAN; LIVER DISEASE; MAJOR CLINICAL STUDY; MALE; PHARMACOEPIDEMIOLOGY; PRESCRIPTION; PRIORITY JOURNAL; RISK REDUCTION; TREATMENT OUTCOME; VETERAN; AGE DISTRIBUTION; COLORECTAL TUMOR; CONFIDENCE INTERVAL; DOSE RESPONSE; DRUG ADMINISTRATION; FOLLOW UP; INCIDENCE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NON INSULIN DEPENDENT DIABETES MELLITUS; REFERENCE VALUE; RISK; RISK ASSESSMENT; SEX RATIO; STATISTICS;

AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; COLORECTAL NEOPLASMS; CONFIDENCE INTERVALS; DIABETES MELLITUS, TYPE 2; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; INCIDENCE; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; ODDS RATIO; REFERENCE VALUES; RISK ASSESSMENT; SEX DISTRIBUTION; VETERANS;

EID: 66949119287     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1038/ajg.2009.64     Document Type: Article

References (33)

1. Gwyn K, Sinicrope FA. Chemoprevention of colorectal cancer. Am J Gastroenterol 2002;97:13-21.
2. Consumer Reports. The Statin Drugs 2006, 1-14, www.consumersunion.org/ StatinAnalysisFinal.pdf.
3. Jakobisiak M, Golab J. Potential antitumor effects of statins (Review). Int J Oncol 2003;23:1055-69.
4. Broitman SA, Wilkinson IV J, Cerda S et al. Effects of monoterpenes and mevinolin on murine colon tumor CT-26 in vitro and its hepatic "metastases" in vivo. Adv Exp Med Biol 1996;401:111-30.
5. Hentosh P, Yuh SH, Elson CE et al. Sterol-independent regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase in tumor cells. Mol Carcinog 2001;32:154-66.
6. Agarwal B, Bhendwal S, Halmos B et al. Lovastatin augments apoptosis induced by chemotherapeutic agents in colon cancer cells. Clin Cancer Res 1999;5:2223-9.
7. Mehta N, Hordines J, Sykes D et al. Low density lipoproteins and Lovastatin modulate the organ-specific transendothelial migration of primary and metastatic human colon adenocarcinoma cell lines in vitro. Clin Exp Metastasis 1998;16:587-94.
8. Pedersen TR, Berg K, Cook TJ et al. Safety and tolerability of cholesterol lowering with simvastatin during 5 years in the Scandinavian Simvastatin Survival Study. Arch Intern Med 1996;156:2085-92.
9. Bjerre LM, LeLorier J. Do statins cause cancer? A meta-analysis of large randomized clinical trials. Am J Med 2001;110:716-23.
10. Coogan PF, Smith J, Rosenberg L. Statin use and risk of colorectal cancer. J Natl Cancer Inst 2007;99:32-40.
11. Kaye JA, Jick H. Statin use and cancer risk in the General Practice Research Database. Br J Cancer 2004;90:635-7.
12. Jacobs EJ, Rodriguez C, Brady KA et al. Cholesterol-lowering drugs and colorectal cancer incidence in a large United States cohort. J Natl Cancer Inst 2006;98:69-72.
13. Graaf MR, Beiderbeck AB, Egberts AC et al. The risk of cancer in users of statins. J Clin Oncol 2004;22:2388-94.
14. Friis S, Poulsen AH, Johnsen SP et al. Cancer risk among statin users: a population-based cohort study. Int J Cancer 2005;114:643-7.
15. Poynter JN, Gruber SB, Higgins PD et al. Statins and the risk of colorectal cancer. N Engl J Med 2005;352:2184-92.
16. Hoffmeister M, Chang-Claude J, Brenner H. Individual and joint use of statins and low-dose aspirin and risk of colorectal cancer: A population-based case-control study. Int J Cancer 2007;121:1325-30.
17. Blais L, Desgagne A, LeLorier J. 3-Hydroxy-3-methylglutaryl coenzyme A reductase inhibitors and the risk of cancer: a nested case-control study. Arch Intern Med 2000;160:2363-8.
18. Vinogradova Y, Hippisley-Cox J, Coupland C et al. Risk of colorectal cancer in patients prescribed statins, nonsteroidal anti-inflammatory drugs, and cyclooxygenase-2 inhibitors: nested case-control study. Gastroenterology 2007;133:393-402.
19. Stagnitti M. Statin Use among Persons 18 and Older in the US Civilian Noninstitutionalized Population Reported as Receiving Medical Care for the Treatment of High Cholesterol. Medical Expenditure Panel Survey, September 2005, Statistical Brief 95.
20. Association AM ICD-9-CM 2007 Physician. 2007.
21. Wong WW, Dimitroulakos J, Minden MD et al. HMG-CoA reductase inhibitors and the malignant cell: the statin family of drugs as triggers of tumor-specific apoptosis. Leukemia 2002;16:508-19.
22. Chan KK, Oza AM, Siu LL. The statins as anticancer agents. Clin Cancer Res 2003;9:10-9.
23. Albano JD, Ward E, Jemal A et al. Cancer mortality in the United States by education level and race. J Natl Cancer Inst 2007;99:1384-94.
24. Sharma S, O'Keefe SJ. Environmental influences on the high mortality from colorectal cancer in African Americans. Postgrad Med J 2007;83:583-9.
25. Yang X, So W, Ko GT et al. Independent associations between low-density lipoprotein cholesterol and cancer among patients with type 2 diabetes mellitus. Cmaj 2008;179:427-37.
26. Ferdinand KC. Managing cardiovascular risk in minority patients. J Natl Med Assoc 2005;97:459-66.
27. Rubin SM, Sidney S, Black DM et al. High blood cholesterol in elderly men and the excess risk for coronary heart disease. Ann Intern Med 1990;113:916-20.
28. Wei JT, Mott LA, Baron JA, et al., Polyp Prevention Study Group. Reported use of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors was not associated with reduced recurrence of colorectal adenomas. Cancer Epidemiol Biomarkers Prev 2005;14:1026-7.
29. Coughlin SS, Calle EE, Teras LR et al. Diabetes mellitus as a predictor of cancer mortality in a large cohort of US adults. Am J Epidemiol 2004;159:1160-7.
30. Yoshida I, Suzuki A, Vallée M et al. Serum insulin levels and the prevalence of adenomatous and hyperplastic polyps in the proximal colon. Clin Gastroenterol Hepatol 2006;4:1225-31.
31. Khurana V, Bejjanki HR, Caldito G et al. Statins reduce the risk of lung cancer in humans: a large case-control study of US veterans. Chest 2007;131:1282-8.
32. Khurana V, Sheth A, Caldito G et al. Statins reduce the risk of pancreatic cancer in humans: a case-control study of half a million veterans. Pancreas 2007;34:260-5.
33. Marquez Cid M, Valera Niñirola I, Chirlaque López MD et al. [Validation of colorectal cancer diagnostic codes in a hospital administration data set]. Gac Sanit 2006;20:266-72.